News By Tag Industry News News By Location Country(s) Industry News
| ![]() HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030Roots Analysis is pleased to announce the publication of its recent study, titled, "HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030."
By: Roots Analysis § A detailed assessment of the current market landscape of companies offering contract services for manufacturing HPAPIs and cytotoxic drugs. § A competitiveness analysis of HPAPI and cytotoxic drugs contract manufacturers, featuring insightful representations. § Detailed profiles of leading contract manufacturers of HPAPI and cytotoxic drugs (shortlisted on the basis of proprietary criterion). § An analysis of the partnerships that have been established in this domain, in the recent past. § An analysis of the various expansion initiatives undertaken by the players in this domain. § An estimate of the overall, installed capacity for manufacturing HPAPIs and cytotoxic drugs based on data reported by industry stakeholders in the public domain. § A qualitative analysis to decide whether to manufacture the potent products in-house or engage the services of a CMO. § A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry's evolution. § A case study on the antibody drug conjugates (ADCs) manufacturing market, highlighting a list of contract service providers and in-house manufacturers in this domain. § A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) § Type of Product § HPAPIs § Highly Potent Finished Dosage Forms § Company Size § Small- § Mid-sized § Large / Very Large § Scale of Operation § Preclinical / Clinical § Commercial § Type of Pharmacological Molecule § Small Molecules § Biologics § Type of Highly Potent Finished Dosage Form § Injectables § Oral Solids § Creams § Others § Key geographical regions § North America § Europe § Asia Pacific § Rest of the World Key companies covered in the report (https://www.rootsanalysis.com/ § AbbVie Contract Manufacturing § CARBOGEN AMCIS § Catalent § Evonik § Formosa Laboratories § Intas § Lonza § MabPlex § Pfizer CentreOne For more information please click on the following link: https://www.rootsanalysis.com/ Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 gaurav.chaudhary@ End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||